Final Program Introduction of CVRFAMG Korea Co., Ltd. is a Korea representative of KANEKA Medix, Asahi Intecc and Elixir Medical, as highly estimated and experienced in interventional market.
Booth No. B12
| Morning Roundtable Forum: Meet the Experts over Breakfast | |
| CTO: Lessons from Data & Experience | |
| Organized by CVRF and Supported by Educational Grant from AMG KOREA CO.,LTD. | |
|
Sunday, April 29 7:00 AM - 8:10 AM CTO Theater, Level 1 |
|
| Moderator(s): Seung-Whan Lee, Barry D. Rutherford, Gerald Werner | |
| Panelist(s): Hiroaki Abe, Yeh Peng Chen, Debabrata Dash, Choong Won Goh, Yuji Hamazaki, Yasumi Igarashi, Arun Kalyanasundaram, Chia-Pin Lin, Ping-Han Lo, Kambis Mashayekhi, Toshiya Muramatsu, Kenya Nasu, Atsunori Okamura, Satoru Otsuji, Xuguang Qin, Ramesh Singh Arjan Singh, Li Wah Tam, Chong Hiok Tan, Eugene Brian Wu | |
| Approaches and Outcomes | |
| 7:00 AM | CTO with LV Dysfunction: Approaches and Outcomes
Lecturer : Kambis Mashayekhi
|
| 7:08 AM | 6ISR CTO: What Is the Difference from De Novo CTO?
Lecturer : Kenya Nasu
|
| 7:16 AM | CHIP and CTO: Perfectibility with Hemodynamic Support
Lecturer : Arun Kalyanasundaram
|
| 7:24 AM | Interactive Discussion with Audience Q&A |
| 7:35 AM | The Lesson from EURO CTO Trial
Lecturer : Gerald Werner
|
| 7:43 AM | The Lesson from DECISION-CTO Trial
Lecturer : Seung-Whan Lee
|
| 7:51 AM | Compared to Medical Therapy, Does CTO PCI Improve Prognosis, or Are the Main Benefits Symptomatic Improvement?
Lecturer : Barry D. Rutherford
|
| 7:59 AM | Interactive Discussion with Audience Q&A |
